Mechanisms of cerebrovascular events as assessed by procoagulant activity, cerebral microemboli, and platelet microparticles in patients with prosthetic heart valves

Stroke

Volumn 29, Issue 9, 1998, Pages 1770-1777

  Geiser, Thomas ^a   Sturzenegger, Matthias ^b   Genewein, Urs ^a   Haeberli, André ^a   Beer, Jürg H ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Neurologische Universitatsklinik Bern   (Switzerland)

Author keywords

Cerebral embolism; Coagulation; Heart valve prosthesis; Platelets; Procoagulant

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; FIBRIN; FIBRINOPEPTIDE A; PHENPROCOUMON; PROCOAGULANT; THROMBIN ANTITHROMBIN COMPLEX;

ADULT; ANTICOAGULATION; ARTICLE; BRAIN EMBOLISM; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART VALVE PROSTHESIS; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOCYTE;

EID: 0031660781     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.9.1770     Document Type: Article

References (43)

1. Cannegieter SC, Rosendaal FR, Wintzen AR, van der Meer FJM, Vandenbroucke JP, Briët E. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med. 1995;333:11-17.
2. Cortelazzo S, Finazzi G, Viero P, Galli M, Remuzzi A, Parenzan L, Barbui T. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic. Thromb Haemost. 1993;69:316-320.
3. Criscitiello MG, Levine HJ. Thromboembolism and prosthetic heart valves. Hosp Pract. 1992;15:69-96.
4. Turpie AGG, Gent M, Laupacis A, Latour Y, Gunstensen J, Basile F, Klimek M, Hirsh J. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med. 1993; 329:524-529.
5. Hanle DD, Harrison EC, Yonagathan AP, Allen TD, Corcoran WH. In vitro flow dynamics of four prosthetic aortic valves: a comparative analysis. J Biomech. 1989;22:597-607.
6. Stein B, Fuster V, Halperin JL, Chesebro JH. Antithrombotic therapy in cardiac disease: an emerging approach based on pathogenesis and risk. Circulation. 1989;80:1501-1513.
7. Markus HS, Harrison MJ. Microembolic signal detection using ultrasound. Stroke. 1995;26:1517-1519.
8. Grosset DG, Georgiadis D, Kelman AW, Lees KR. Quantification of ultrasound embolic signals in patients with cardiac and carotid disease. Stroke. 1993;24:1922-1924.
9. Dagirmanjian A, Davis DA, Rothfus WE, Deeb ZL, Goldberg AL. Silent cerebral microemboli occurring during carotid angiography: frequency as determined with Doppler sonography. AJR Am J Roentgenol. 1993;161: 1037-1040.
10. Spencer MP, Thomas GI, Nicholls SC, Sauvage LR. Detection of middle cerebral artery emboli during carotid endarterectomy using transcranial Doppler ultrasonography. Stroke. 1990;21:415-423.
11. Russell D, Madden KP, Clark WM, Sandset PM, Zivin JA. Detection of arterial emboli using Doppler ultrasound in rabbits. Stroke. 1991;22: 253-258.
12. Georgiadis D, Grosset DG, Kelman A, Faichney A, Lees KR. Prevalence and characteristics of intracranial microemboli signals in patients with different types of prosthetic heart valves. Stroke. 1994;25:587-592.
13. Georgiadis D, Kaps M, Siebler M, Hill M, Konig M, Berg J, Kahl M, Zunker P, Diehl B, Ringelstein EB. Variablitiy of Doppler microemboli signal counts in patients with prosthetic cardiac valves. Stroke. 1995;26: 439-443.
14. Grosset DG, Cowburn P, Georgiadis D, Dargie HJ, Faichney A, Lees KR. Ultrasound detection of cerebral emboli in patients with prosthetic heart valves. J Heart Valve Dis. 1994;3:128-132.
15. Chow TW, Hellums JD, Moake JL, Kroll MH. Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation. Blood. 1992;80:113-120.
16. McGill M, Fugman DA, Vittorio N, Darrow C. Platelet membrane vesicles reduced micro-vascular bleeding times in thrombocytopenic rabbits. J Lab Clin Med. 1987;109:127-133.
17. Mann KG. Membrane-bound enzyme complexes in blood coagulation. In: Progress of Hemostasis and Thrombosis. New York, NY: Grune & Stratton; 1984:1-23.
18. Gawaz M, Ott J, Reininger AJ, Heinzmann U, Neumann FJ. Agglutination of isolated platelet membranes. Arterioscler Thromb Vasc Biol. 1996;16:621-627.
19. Sturzenegger M, Beer JH, Rihs, F. Monitoring combined antithrombotic treatments in patients with prosthetic heart valves using transcranial Doppler and coagulation markers. Stroke. 1995;26:63-69.
20. Genewein U, Haeberli A, Straub PW, Beer JH. Rebound after cessation of oral anticoagulant therapy: the biochemical evidence. Br J Haematol. 1996;92:479-485.
21. Nomura S, Nagata H, Suzuki M, Kondo K, Ohga S, Kawakatsu T, Kido H, Fukuori T, Yamaguchi K, Iwata K. Microparticle generation during in vitro platelet activation by anti-CD9 murine monoclonal antibodies. Thromb Res. 1991;62:429-439.
22. Warkentin TE, Hayward CPM, Boshkov LK, Santos AV, Sheppard JA, Bode AP, Kelton JG. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood. 1994;84:3691-3699.
23. Kaps M, Hansen J, Weiher M. Tiffert K, Kayser J, Droste DW. Clinically silent microemboli in patients with artificial prosthetic heart valves are predominantly gaseous and not solid. Stroke. 1997;28:322-325.
24. Malmgren R, Thorsen T, Nordvik A, Holmsen H. Microbubble-induced phospholipase C activation does not correlate with platelet aggregation. Thromb Haemost. 1993;69:394-396.
25. Softeland E, Framstad T, Nordvik A, Strand I, Thorsen T, Holmsen H. Nitrogen microbubbles induce a disappearance of single platelets (aggregation) with porcine platelets: a comparative study of the effects of anticoagulants and blood collection methods. Thromb Res. 1994;76: 61-70.
26. 2-microbubbles in platelet rich plasma in an aggregometer-like apparatus, and effect on the platelet density in vitro. Undersea Biomed Res. 1986;13:271-288.
27. 2-microbubble-activated human platelets in vitro. Undersea Biomed Res. 1987;14:45-59.
28. Malmgren R, Thorsen T, Lie RT, Holmsen H. Microbubble-induced serotonin secretion in human platelets. Thromb Haemost. 1991;65: 399-402.
29. Hennerici MG. High intensity transcranial signals (HITS): a questionable "jackpot" for the prediction of stroke risk. J Heart Valve Dis. 1994;3: 124-125. Editorial.
30. Brown MM, Markus HS. Transcranial Doppler detection of asymptomatic cerebral microemboli. J Heart Valve Dis. 1994;3:126-127.
31. Lee LH, Baglin T. Altered platelet phospholipid-dependent thrombin generation in thrombocytopenia and thrombocytosis. Br J Haematol. 1995;89:131-136.
32. Tans G, Rosing J, Thomassen MC, Heeb MJ, Zwaal RFA, Griffin JH. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood. 1991;77:2641-2648.
33. Sims PJ, Wiedmer T, Esmon CT, Weiss HJ, Shattil SJ. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane: studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem. 1989;264:17049-17057.
34. Beer JH, Coller BS, Siegenthaler C. The membrane sidedness of platelet microparticles, as judged by an antibody to the C-terminus of GPIIIa, depends on the mechanism of their production. Thromb Haemost. 1991: 65:1068a.
35. Comfurius P, Senden JMG, Tilly RHJ, Schroit AJ, Bevers EM, Zwaal RFA. Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase. Biochim Binphys Acta. 1990;1026:153-160.
36. Gawaz M, Neumann FJ, Ott I, Schiessler A, Schömig A. Platelet function in acute myocardial infarction treated with direct angioplasty. Circulation. 1996;93:229-237.
37. Lee YJ, Jy W, Horstman LL, Janania J, Reyes Y, Kelley RE, Ahn YS. Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. Thromb Res. 1993;72:295-304.
38. Kelton JG, Warkentin TE, Hayward PM, Murphy WG, Moore JC. Calpain activity with thrombotic thrombocytopenia purpura is associated with platelet microparticles. Blood. 1992;80:2246-2251.
39. Kojima H, Newton-Nash D, Weiss HJ, Zhao J, Sims PJ, Wiedmer T. Production and characterization of transformed B-lymphocytes expressing the membrane defect of Scott syndrome. J Clin Invest. 1994; 94:2237-2244.
40. Hemker H, Beguin S. How to measure the relevant effect of anticoagulant treatment on the coagulability of plasma. In: Thrombosis and Its Management. Edinburgh, UK: Churchill Livingstone; 1993:3-14.
41. Bevers E, Comfurius P, Zwaal R. Platelet procoagulant activity: physiological significance and mechanisms of exposure. Blood Rev. 1991;5: 146-154.
42. Gemmell CH, Sefton MV, Yeo EL. Platelet-derived microparticle formation involves glycoprotein IIb-IIIa. J Biol Chem. 1993;268: 14586-14589.
43. Konstantopoulos K, Kamat SG, Schafer AI, Banez EL, Jordan R, Kleiman NS, Hellums JD. Shear-induced platelet aggregation is inhibited by in vivo infusion of an anti-glycoprotein IIb/IIIa antibody fragment, c7E3 Fab, in patients undergoing coronary angioplasty. Circulation. 1995;91:1427-1431.